Forfivo - 49909-010-30 - (bupropion hydrochloride)

Alphabetical Index


Drug Information of Forfivo

Product NDC: 49909-010
Proprietary Name: Forfivo
Non Proprietary Name: bupropion hydrochloride
Active Ingredient(s): 450    mg/1 & nbsp;   bupropion hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Forfivo

Product NDC: 49909-010
Labeler Name: Edgemont Pharmaceuticals, LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022497
Marketing Category: NDA
Start Marketing Date: 20121001

Package Information of Forfivo

Package NDC: 49909-010-30
Package Description: 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (49909-010-30)

NDC Information of Forfivo

NDC Code 49909-010-30
Proprietary Name Forfivo
Package Description 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (49909-010-30)
Product NDC 49909-010
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name bupropion hydrochloride
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20121001
Marketing Category Name NDA
Labeler Name Edgemont Pharmaceuticals, LLC
Substance Name BUPROPION HYDROCHLORIDE
Strength Number 450
Strength Unit mg/1
Pharmaceutical Classes Aminoketone [EPC],Dopamine Uptake Inhibitors [MoA],Increased Dopamine Activity [PE],Increased Norepinephrine Activity [PE],Norepinephrine Uptake Inhibitors [MoA]

Complete Information of Forfivo


General Information